- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bill Would Establish V-BID Demonstration in Medicare Advantage
A bipartisan effort reintroduced legislation that would establish a demonstration in Medicare Advantage to evaluate the use of value-based insurance design's ability to reduce copayments and coinsurance for some Medicare Advantage beneficiaries, reported the University of Michigan Center for Value-Based Insurance Design.
A bipartisan effort reintroduced legislation that would establish a demonstration in Medicare Advantage to evaluate the use of value-based insurance design (V-BID)'s ability to reduce copayments and coinsurance for some Medicare Advantage beneficiaries, reported the University of Michigan Center for Value-Based Insurance Design.
The program would focus on beneficiaries with specific chronic conditions to see if the use of certain high-value medications and services resulted in improved health outcomes and reduced spending.
“With V-BID, a promising health insurance concept, both patients and taxpayers win, proving that if money can be spent in a more targeted, effective way, it’s also possible to improve the value of care delivered," said US Senator John Thune (R-SD).
Debbie Stabenow (D-Mich) added that the reintroduction of this legislation was a "win-win" as it improves care and lowers insurance costs.
Read more at the V-BID Center's website: http://bit.ly/1BiHTWA
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
November 10th 2023This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More
